Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL S...

FDA Drug Recall #D-0305-2021 — Class II — March 11, 2021

Recall Summary

Recall Number D-0305-2021
Classification Class II — Moderate risk
Date Initiated March 11, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sagent Pharmaceuticals Inc
Location Schaumburg, IL
Product Type Drugs
Quantity 3716 cartons

Product Description

Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.

Reason for Recall

Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Lot / Code Information

Lots: PHT8IB2, PHT9IB2, exp 08/2022; PHT1JB2, exp 09/2022

Other Recalls from Sagent Pharmaceuticals Inc

Recall # Classification Product Date
D-0764-2023 Class II Nafcillin for Injection, USP, 10 gram per Pharm... May 19, 2023
D-0762-2023 Class II Nafcillin for Injection, USP, 1 gram per vial, ... May 19, 2023
D-0763-2023 Class II Nafcillin for Injection, USP, 2 gram per vial, ... May 19, 2023
D-0435-2023 Class II Heparin Sodium Injection, USP, 20,000 USP units... Feb 28, 2023
D-1274-2019 Class II Ketorolac Tromethamine Injection, USP, 60 mg pe... Apr 30, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.